INTRODUCTION
Migrant populations are of special interest to the cancer epidemiologist since migration provides an opportunity to compare disease risk in populations of similar genetic background living in different environments (1). The differences in risk observed, and incidence following migration. The province of Alberta has a substantial foreign-born population and routinely collects information on place of birth for all cancer cases entered into the provincial cancer registry, thus making it possible to conduct research on the impact of migration on cancer incidence.
Prior research in the USA and Australia has established that Chinese immigrants tend to carry with them the high risks for "traditional" cancers found in China (e.g. nasopharyngeal, esophageal, liver and stomach) while at the same time retaining low risks for certain "Western" cancers (e.g. prostate, female breast, and bladder cancer) (8) (9) (10) (11) .
We found no literature comparing cancer incidence between Chinese immigrants and the Canadian-born population in Canada. This paper examines cancer incidence for three groups (Chinese immigrants to Canada, Canadian born residents, and residents of Shanghai) between 1974 and 1993.
MATERIALS AND METHODS

Cancer Incidence Data
Cancer incidence data were obtained from both the Alberta Cancer Registry (ACR) and the Shanghai Cancer Registry. Under provincial legislation, the ACR obtains all reports mentioning a malignancy from six main sources: cancer agencies, pathology laboratories, haematology laboratories, death certificates, hospitals and autopsy reports. From 1969 to 1988, 92-94% of all cancer cases in ACR were microscopically confirmed (12) . The ACR is a patient registry, rather than a tumour registry, thus making the recording and finding of multiple primaries, bilateral tumours, etc. more accurate (13) . All death certificates can be linked with cancer records by computer through the Department of Vital Statistics. An annual follow-up programme has been initiated to supplement the data collected on the initial events regarding diagnosis and treatment. All the cancer cases are classified according to the 4-digit rubrics of the 9th Revision of the International Classification of Disease (ICD9) and the International Classification of Disease Oncology (ICD-O; version 1 pre-1992, version 2 post-1992) (13) .
Alberta was chosen as the study population since the ACR routinely collects birthplace information. There is also a substantial population of Chinese origin in Alberta (71,635, accounting for 12% of the total population with Chinese ancestry in Canada, 1991) (14) . The other provinces with large proportions of Chinese either do not record birthplaces (Ontario with 47% of the Canadian Chinese population), or have incomplete data on birthplace (British Columbia with 30% of the Chinese population) (7) .
The Alberta Cancer Registry database was used to identify all cases of cancer (ICD9 codes 140-208, excluding 173 with non-melanoma skin cancer) occurring in the province between 1974 and 1993. While the Registry contains information prior to 1973, the recording of birthplace was largely incomplete and these cases were excluded from the analysis. The following information was abstracted from the computer records: date of diagnosis, date of birth, age at diagnosis (calculated), recorded age group, patient status (alive or dead), sex, primary site number, birthplace code, residence, method of diagnosis, ICDOTopography, ICDO-Morphology, ICD9 code, and reporting province. The birthplace variable was used to identify Canadian-born and Chinese-born populations of Alberta residents. In order to be comparable with other studies and to obtain sufficient cancer cases, people born in Hong Kong, PR China, and Taiwan were grouped as "Chinese immigrants."
Chinese birthplace was identified using standard codes from the National Cancer Incidence Reporting System (codes 9574 (PR China), 9577 (Hong Kong), and 9585 (Taiwan) from 1974 to 1991 (15) ) and from the Canadian Cancer Registry (birthplace codes 156, 344, and 158 respectively for years 1992-1993 (16)). Canadian-born incident cases were identified by Canadian birthplace codes 1000-6100 (with provincial coding) and 9995 (without provincial codes) for 1974-1991 (15) and birthplace codes 910-961 and 909 respectively from 1992 to 1993 (16) . Both the Canadian-born population and the Chinese-born immigrants were limited to Alberta residents at the time of diagnosis (place of residence code 48) in order to match the population at risk (census population).
The year of diagnosis was grouped into four time periods : 1974-1978, 1979-1983, 1984-1988, and 1989-1993 with intervals centered on the Census years. Age was categorized into six groups: 0-24, 25-49, 50-59, 60-69, 70-79 and 80+. The larger intervals at the younger age groups are due to the low incidence of cancer in these age groups.
Cancer incidence rates for Shanghai were obtained from the series of publications "Cancer Incidence in Five Continents, Vol. IV-VII" for the period of 1975-1992 (13, 19, 20) . The original source of the data used in this publication was the Shanghai Cancer Registry. The Shanghai Cancer Registry is the only cancer registry in the PR China with a long history and high quality data (19) . The population-based Shanghai Cancer Registry started systematically collecting information on cancer mortality in 1963 and cancer incidence in 1972 (17) . Under the legislation concerning the notification of cancer cases issued by the Shanghai Municipal Bureau of Public Health, all medical facilities in Shanghai are obliged to report all newly diagnosed cancer cases of in-and out-patients.
A standardized notification card, which includes information on name, date of birth, sex, address, occupation, cancer site, date, and methods of diagnosis is used for reporting cancer cases. Since 1987, a computerized cancer registration system has been established based on Chinese characters. The basic functions of the system mainly consist of data management, duplication deletion, statistics, and graphing (13) . Every year the registry obtains information on the vital status of cancer patients by passive follow-up. The cancer registry obtains monthly notifications of all deaths of people diagnosed with cancer from the section of vital statistics, which is linked with the notification cards of cancer cases at the end of a year. All the cancers are classified according to ICD9 (13) . Both Alberta and Shanghai cancer registries have been contributing registries to the IARC and International Association of Cancer Registries (IACRs) since 1978.
Cancer Sites for Analysis
Since the main purpose of the project is to compare the cancer incidence rates between the Canadian-born population in Alberta and Chineseborn immigrants to Alberta, it was decided to limit analysis to cancer sites which were common in either Canada, China, or both countries. The following cancer sites were chosen for the analysis (the ICD9 code follows the cancer type): nasopharynx (147), esophagus (150), stomach (151), colon (153), rectum (154), liver (155), pancreas (157), lung (162), bladder (188), prostate (185, males only), breast (174, females only), cervix (180, females only), uterus (182, females only), ovary (183, females only). "All cancer combined, except 173" refers to all cancer sites (ICD9 140-208) but excludes non-melanoma skin cancer (ICD9 code 173).
Population Data
The person-years at risk were obtained from customized tabulations provided by the Reference Centre of Statistics Canada. Four tables (for the census years of 1971, 1981, 1986 , and 1991) were obtained listing the number of Alberta residents by birthplace, ethnic origin, five-year age groups (0-4, 5-9, . . . , 80-84, 85+), sex, age at immigration, and year of immigration. The birthplace was coded as Canada, Hong Kong (HK), PR China (PRC), or Taiwan (TW). Data from three birthplace locations (HK, PRC, TW) were pooled to identify the first-generation immigrants from "China." In the census year for 1976, the information of birthplace was not collected in the census questionnaire (21) . Therefore, the population by birthplace or 1976 was interpolated by averaging the 1971 and 1981 census populations within age groups. The denominator of the five-year incidence rate was obtained by multiplying by five the population counts of the census year associated with the study period.
Statistical Methods
Age-and gender-specific incidence rates were obtained by dividing the observed number of cases by the estimated person-years at risk. Age-standardized incidence rates (ASIRs) were obtained by the direct method using the "world standard" population (22) as the referrent. ASIRs per 100,000 person-years were calculated using the six age groups (0-24, 25-49, 50-59, 60-69, 70-79, and 80+) during each of the four study periods (1974-78, 1979-83, 1984-88, and 1989-93) for each cancer site of interest. The standard error and the 95% confidence interval of the ASIRs were calculated using the method provided in the "Cancer Registration Principles and Methods" (23).
The age-standardized incidence rate ratio (i.e. comparative incidence figure (CIF)) of Chinese immigrants and Canadian-born population was calculated by dividing the ASIR of Chinese immigrants by the ASIR of the Canadian-born population. This provides a comparison of the relative incidence rates in these two populations in the four study periods (Canadianborn population as reference group). An analogous CIF comparing the Chinese immigrants and Shanghai Chinese was calculated during the four study periods (Shanghai Chinese as reference group). The confidence interval of the CIF was calculated based on the method from Breslow and Day (24) .
RESULTS
Descriptive Analysis
A total of 31,576 male and 32,536 female cases of cancer (excluding non-melanoma skin cancer) were diagnosed in Canadian-born Alberta residents during the period of 1974-1993. During the same time, a total of 640 male and 583 female cancer cases were diagnosed in Chinese immigrants. For Chinese in Shanghai, the total cancer cases during the years of 1975 and 1978-1992 
ASIRs
The ASIRs among the three populations for the entire 20 years (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) are presented in Table I (males), Table II (females), and Figs. 1 and 2. For all cancers (excluding with non-melanoma skin cancer), Chinese male immigrants had the lowest ASIR compared with Canadian-born and Chinese in Shanghai, while Chinese females had a lower ASIR compared with Canadian-born population and a slightly higher ASIR compared with Chinese in Shanghai all through the 20-year period.
The ASIR of nasopharyngeal cancer was highest in the Chinese immigrants (both males and females). The ASIRs for stomach and liver cancer (males and females) and for esophageal cancer (males only) were consistently much lower in the immigrants than in the Shanghai Chinese. For liver cancer, the rates in the immigrants were higher than in Canadian-born subjects. However, for esophageal and stomach cancer, the rates in immigrants and Canadian-born subjects were similar. In contrast, the ASIRs of prostate cancer in Chinese male immigrants and breast cancer in Chinese female immigrants were higher than that in Shanghai residents but were lower than in Canadian-born residents. A similar, but less extreme pattern, was found for colon cancer.
Chinese male and female immigrants had the lowest ASIRs for lung and bladder cancers. The ASIRs of rectum and pancreatic cancers in Chinese female immigrants were also the lowest compared with Canadian-born and Shanghai females. 
Comparative Incidence Figure (CIFs)
DISCUSSION
Cancer incidence in Chinese migrants to Canada shows a pattern in which the immigrants generally have rates intermediate between Canadian-born subjects and people living in Shanghai. In general, the rates in the immigrants are closer to those of the Canadian-born. However, for liver cancer, the incidence rate is closer to that found in Shanghai and is much higher than found in Canadian-born subjects. Much of the liver cancer risk is likely due to Hepatitis B infection in early life and so would be little affected by changes in lifestyle after immigration.
Nasopharyngeal cancer, another "traditional" Chinese malignancy, had a higher incidence in Chinese male and female immigrants when compared to both Canadian-born Alberta residents and Shanghai Chinese. This observation also appeared in two other Canadian studies (3, 4) . The very high incidence compared to Canadian-born subjects (30-50 times higher) suggests that the immigrants have maintained their high risk for this cancer. The comparison with Shanghai may reflect a bias. A large portion of Chinese immigrants from Hong Kong traces their origins to the Cantonese-speaking province of Guangdong in PR China, where the highest rate of nasopharynx cancer is found in the world. It is possible that Cantonese immigrants carried their specific risk with them when they migrated from Hong Kong or PR China and that the Shanghai Registry is underrepresenting the appropriate incidence in China. It has long been recognized that Epstein-Barr virus infection in early childhood is associated with this cancer. Prostate and female breast cancers remain uncommon in Chinese immigrant men and women respectively, which suggests that early life events (perhaps during puberty) might exert a lifetime protective effect. This would be consistent with recent suggestions that the physical activity or diet during teenage years can affect the risk of developing breast cancer (25) . The risk ratios of prostate cancer in Chinese male immigrants and breast cancer in Chinese female immigrants are significantly higher than those in Shanghai Chinese males and females respectively. This could be the result of the earlier diagnosis of cases of breast and prostate cancers in Chinese immigrants than in Shanghai Chinese due to the lack of screening programs for these two types of cancer in PR China.
The ASIR of "all cancer combined" (ICD9 140-208, excluding non-melanoma skin cancer) of Chinese male and female immigrants was still significantly lower than that of the Canadian-born population during the entire 20-year period. These results confirm those of other studies (3, 26) .
Chinese male immigrants had a significantly lower ASIR of lung cancer than Shanghai males and a marginally lower (not significant) ASIR than (28) . The healthy immigrant effect could also contribute to the lower lung cancer ASIR in Chinese immigrants. Results of some previous studies found that Chinese male immigrants had a higher ASIR (or SMR) for lung cancer than populations in the adopted countries (4, 29) while other studies reported results similar to those from the present study (8, 9) . A lower ASIR of lung cancer in Chinese female immigrants than in Canadian-born females is possibly due to the lower smoking rate in this ethnic group (28) . Cooking oil is considered as a risk factor for Chinese female lung cancer (30) . The reduced lung cancer risk in Chinese female immigrants compared to Chinese women in Shanghai, could possibly be explained by the better cooking oil quality and kitchen conditions in Canada compared with that in PR China.
The quality of the data used in this study should be high. Both the Alberta and Shanghai Cancer Registries have participated in the IARC international collaboration project, follow IARC guidelines, and have demonstrated the quality of their data. The basic aims of the IARC international collaboration project are to improve quality of data on cancer incidence and comparability between registries by standardizing methods of registration, definitions, and coding, as well as to disseminate information on the multiple uses of cancer registry data in the planning and evaluation of cancer prevention and therapy, and in epidemiological research into the causes of cancer. It is estimated that both registries identify 90% or more of cancer cases. The population counts were derived from special tabulations based on the Canadian censuses of 1971, 1986, and 1991, which enabled a more precise calculation of person-years of exposure by birthplace than would have been possible using published tables.
Some limitation to this study should be acknowledged. Place of origin at the provincial level within PR China was not available for either the cancer registry or population data, and national cancer incidence rate is not available for China. The Shanghai Cancer Registry data were the best available for comparing cancer incidence in Alberta with that in China. However, incidences from the Shanghai registry are not representative of the whole nation of PR China. Further, it was not possible to adjust for regional differences when comparing cancer incidence among Chinese immigrants with that among the Chinese in China.
Cancer incidence in the second generation of Chinese immigrants could not be obtained, since information on the ethnicity of an individual is neither available in the Alberta Cancer Registry data, nor in any other provincial cancer registry in Canada. Moreover, no information on duration of stay or age at immigration was available for Chinese immigrants. Therefore, valuable information on the time dimension could not be examined to study the speed with which any change in disease risk occurred.
Recommendations
Canada is a country with a multi-cultural population ideal for studying disease causation. Health records on immigrants could be collected and followed for monitoring special diseases. Information on ethnicity, birthplace, time of migration, and duration of stay would be very useful to determine the risk factors and interpret patterns of certain diseases. This information should be collected in the Canadian census and provincial cancer registries should collect as much detail as possible.
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